1. Home
  2. CODA vs TLSA Comparison

CODA vs TLSA Comparison

Compare CODA & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODA
  • TLSA
  • Stock Information
  • Founded
  • CODA 1994
  • TLSA 2013
  • Country
  • CODA United States
  • TLSA United Kingdom
  • Employees
  • CODA N/A
  • TLSA N/A
  • Industry
  • CODA Industrial Machinery/Components
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CODA Industrials
  • TLSA Health Care
  • Exchange
  • CODA Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • CODA 92.5M
  • TLSA 87.8M
  • IPO Year
  • CODA N/A
  • TLSA 2000
  • Fundamental
  • Price
  • CODA $7.82
  • TLSA $0.64
  • Analyst Decision
  • CODA Strong Buy
  • TLSA
  • Analyst Count
  • CODA 1
  • TLSA 0
  • Target Price
  • CODA $11.00
  • TLSA N/A
  • AVG Volume (30 Days)
  • CODA 37.3K
  • TLSA 1.2M
  • Earning Date
  • CODA 03-17-2025
  • TLSA 02-18-2025
  • Dividend Yield
  • CODA N/A
  • TLSA N/A
  • EPS Growth
  • CODA 14.29
  • TLSA N/A
  • EPS
  • CODA 0.32
  • TLSA N/A
  • Revenue
  • CODA $20,316,161.00
  • TLSA N/A
  • Revenue This Year
  • CODA $22.31
  • TLSA N/A
  • Revenue Next Year
  • CODA $12.02
  • TLSA N/A
  • P/E Ratio
  • CODA $24.41
  • TLSA N/A
  • Revenue Growth
  • CODA 4.98
  • TLSA N/A
  • 52 Week Low
  • CODA $5.42
  • TLSA $0.41
  • 52 Week High
  • CODA $9.89
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • CODA 41.62
  • TLSA 38.37
  • Support Level
  • CODA $7.75
  • TLSA $0.65
  • Resistance Level
  • CODA $8.13
  • TLSA $0.70
  • Average True Range (ATR)
  • CODA 0.34
  • TLSA 0.08
  • MACD
  • CODA -0.05
  • TLSA -0.01
  • Stochastic Oscillator
  • CODA 7.22
  • TLSA 3.97

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: